CRISPR-Focused Biotech Co-Founded By Forbes Under 30 Alumnus Raises $76 Million – Forbes
|
CRISPR-Focused Biotech Co-Founded By Forbes Under 30 Alumnus Raises $76 Million
Forbes KSQ Therapeutics, a biotechnology company co-founded by a member of Forbes' 2107 30 Under 30 list, has raised $26 million and appointed a high-profile chief executive. Tim Wang, then a graduate student at MIT, co-founded KSQ with David Sabatini of … |
